Deutsche Bank initiated coverage on DocGo with a new price target
$DCGO
Medical/Nursing Services
Health Care
Deutsche Bank initiated coverage of DocGo with a rating of Buy and set a new price target of $11.00
Save time and jump to the most important pieces.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/9/2025 | Buy → Neutral | BTIG Research | |
| 2/28/2025 | $5.00 → $2.85 | Buy → Hold | Deutsche Bank |
| 8/18/2023 | $15.00 | Buy | BTIG Research |
| 4/21/2023 | $11.00 | Overweight | Cantor Fitzgerald |
| 4/19/2022 | $11.00 | Buy | Deutsche Bank |
| 1/19/2022 | $14.00 | Buy | Stifel |
| 12/21/2021 | $13.00 | Buy | Canaccord Genuity |
| 12/7/2021 | $14.00 | Buy | Needham |
Prestigious International Annual Awards Program Recognizes Standout Digital Health & Medical Technology Products and Companies DocGo Inc. (NASDAQ:DCGO) ("DocGo"), a leading provider of technology-enabled mobile health services, today announced that it has been selected as winner of the "Compliance Management Innovation Award" in the 9th annual MedTech Breakthrough Awards program conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies and products in the global digital health and medical technology market. DocGo's breakthrough Compliance Program excels at adapting to the organization's dynamic environment and consis
Company Focuses on Growing Medical Transportation and Payer & Provider Businesses, Navigates Municipal Uncertainty and Migrant Services Transition Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the quarter ended March 31, 2025. Lee Bienstock, Chief Executive Officer of DocGo, commented, "The impact of ongoing policy changes in Washington and adjustments to public spending on healthcare-related projects have created substantial uncertainty in our Government Populati
Management to host conference call and webcast at 5:00 p.m. ET on that day DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, announced today that the Company will release its financial results for the first quarter ended March 31st, 2025 after the markets close on Thursday, May 8th, 2025. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Thursday, May 8th, 2025 5:00 p.m. ET 1-800-717-1738 (U.S.) 1-646-307-1865 (international) Conference ID: 65854 To access the Call me™ feature, which avoids the need to wait for an operator, click https:
10-Q - DocGo Inc. (0001822359) (Filer)
8-K - DocGo Inc. (0001822359) (Filer)
SCHEDULE 13G - DocGo Inc. (0001822359) (Subject)
4 - DocGo Inc. (0001822359) (Issuer)
4 - DocGo Inc. (0001822359) (Issuer)
4 - DocGo Inc. (0001822359) (Issuer)
4 - DocGo Inc. (0001822359) (Issuer)
4 - DocGo Inc. (0001822359) (Issuer)
4 - DocGo Inc. (0001822359) (Issuer)
DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced the acquisition of PTI Health, a mid-Atlantic mobile lab collection and phlebotomy services company. This strategic move expands DocGo's healthcare service offering to include mobile phlebotomy lab services, addressing critical gaps in diagnostic care for underserved populations. With this acquisition, DocGo will facilitate timely, convenient blood collection and additional at-home testing services for patients, offering a new level of care to those with limited access to traditional labs or transportation options. The acquisition enhances DocGo's offerings
DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced the appointment of Stephen K. Klasko, M.D., M.B.A as the new independent, non-executive Chair of its Board of Directors, effective October 1, 2024. Dr. Klasko has an extensive background in leadership roles within healthcare, higher education and medical industry innovation, including an eight-year tenure as the President of Thomas Jefferson University and the CEO of Jefferson Health where he oversaw its expansion to 18 hospitals and over 35,000 employees. Prior to that, he was CEO of USF Health and Dean of the Morsani College of Medicine at the University o
DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-driven healthcare solutions, is proud to announce Eiwe Lingefors as Chief Information Officer (CIO). Lingefors most recently served as the company's Chief Information Security Officer, and will continue in this role as well. In his new role as CIO, Lingefors will lead both DocGo's information security and digital innovation strategy in an evolving cybersecurity landscape. "Eiwe has been a vital part of our team, and his deep expertise in the security landscape has been instrumental in DocGo's operations," said Lee Bienstock, CEO of DocGo. "He has done an excellent job strengthening DocGo's existing cybers
Company Focuses on Growing Medical Transportation and Payer & Provider Businesses, Navigates Municipal Uncertainty and Migrant Services Transition Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the quarter ended March 31, 2025. Lee Bienstock, Chief Executive Officer of DocGo, commented, "The impact of ongoing policy changes in Washington and adjustments to public spending on healthcare-related projects have created substantial uncertainty in our Government Populati
Management to host conference call and webcast at 5:00 p.m. ET on that day DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, announced today that the Company will release its financial results for the first quarter ended March 31st, 2025 after the markets close on Thursday, May 8th, 2025. Management will also host a conference call to discuss these results at 5:00 p.m. ET on that day. Conference call and webcast details: Thursday, May 8th, 2025 5:00 p.m. ET 1-800-717-1738 (U.S.) 1-646-307-1865 (international) Conference ID: 65854 To access the Call me™ feature, which avoids the need to wait for an operator, click https:
Company Surpasses 700,000 Total Patient Lives Assigned for Care Gap Closure Programs and Expands Contracts With Payer Partners on Both Coasts Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced financial and operating results for the quarter and full-year ended December 31, 2024. Full-Year 2024 Financial Highlights Full-year 2024 revenue was $616.6 million, compared to $624.2 million for the full-year 2023. GAAP gross margin (which includes non-cash depreciation expenses) for the full-year 2024 was 32.1%, compared to 28.7%
BTIG Research downgraded DocGo from Buy to Neutral
Deutsche Bank downgraded DocGo from Buy to Hold and set a new price target of $2.85 from $5.00 previously
BTIG Research initiated coverage of DocGo with a rating of Buy and set a new price target of $15.00
SC 13D/A - DocGo Inc. (0001822359) (Subject)
SC 13G/A - DocGo Inc. (0001822359) (Subject)
SC 13G/A - DocGo Inc. (0001822359) (Subject)